# Olema Pharmaceuticals Inc. (OLMA) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $7.35, market value $643 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Olema Pharmaceuticals Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 1.5×**. The shares trade at 1.5× book value; book value is a meaningful part of the valuation.

## Profitability
- **Return on equity: -33.9%**. Return on equity is negative because earnings are negative.

## Growth
- **EPS growth (1 yr): 15.0%**. Earnings per share rose 15.0%.

## Financial health
- **Current ratio: 9.95** (quick 9.95). Current assets cover the next year's liabilities 9.95 times.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Olema Pharmaceuticals Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -21.2%** (YTD -71.7%, 3-mo -37.3%). The shares are down 21.2% over twelve months including dividends.
- **From 52-week high: -79.7%** (17.9% above the low). Trading 80% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 41**. An RSI of 41 is neutral.
- **Beta (1 yr): 0.49** (volatility 153%). Beta of 0.49 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OLMA · Page: https://foliofundamentals.com/stocks/olma

Not investment advice.